Developing Ethical Guidelines for the Use of Artificial Intelligence in Speech-Language Pathology Practice in Pakistan: A Mixed-Methods Study
DOI:
https://doi.org/10.59075/7a1f5j57Keywords:
artificial intelligence; ethics; speech-language pathology; Pakistan; mixed methods; Delphi; cultural validity; data privacy; professional accountabilityAbstract
Artificial intelligence (AI) is revolutionizing healthcare services around the world, such as speech-language pathology (SLP). In Pakistan, SLP is still a developing profession with only a few regulatory bodies, there are no formal codes of ethics for the use of AI in clinical practice. The purpose of this mixed-methods study was to create an ethical framework for the application of AI in Pakistani SLP practice that is grounded in the local context. The aim of this mixed-methods study was to develop a contextually appropriate ethical framework regarding the use of AI in the practice of SLP in Pakistan. This consisted of a three-phase sequential study design: an online survey of 172 SLP practitioners, four focus groups with clinicians, academics, and students, and a two-round Delphi consensus process with 18 experts. The quantitative analysis consisted of reliability test, exploratory factor analysis, t-test, ANOVA and multiple linear regression. It was found that 55.2% of respondents were using large language models (LLDMs) in clinical documentation. Cultural-linguistic validity, data privacy and professional accountability were some of the larger ethical issues. The ethical concern scale was highly reliable (α = .91) and factor analysis revealed four factors. The Delphi consensus led to the development of ten ethical guidelines, with at least 87% expert agreement. These guidelines offer a pragmatic approach for ethical application of AI in the context of SLP practice in Pakistan.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The Critical Review of Social Sciences Studies

This work is licensed under a Creative Commons Attribution 4.0 International License.
















